Clinical trials in Aachen – page 13

290 clinical trials in Aachen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Aachen at a glance

290

clinical trials

Research sites1

Quick filters

290 trials in Aachen

Open in trial search

Diffuse large B-cell lymphoma+2

Not yet recruiting

Registered drugNo placebo

Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Epcoritamab
Sponsor:Universitaet Muenster

Contact Research Centre

Immune-mediated myositis

Not yet recruiting

Registered drugNo placebo

Study on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide
Sponsor:Novartis Pharma AG

Contact Research Centre

Sickle cell disease

Not yet recruiting

Investigational

Study of GBT021601 for Adults and Children with Sickle Cell Disease

Investigational

Germany

Participants:0–17 years · 18–64 years
Substances:(S)-2-Hydroxy-6-((4-(2-(2-Hydroxyethyl)Nicotinoyl)Morpholin-3-Yl)Methoxy)Benzaldehyde
Sponsor:Global Blood Therapeutics Inc.

Contact Research Centre

Pancreatic carcinoma metastatic

Not yet recruiting

Registered drugNo placebo

Study on Chemotherapy with Liposomal Irinotecan, Oxaliplatin, and 5-Fluorouracil for Patients with Pancreatic Cancer Spread to the Liver

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:University Of Cologne

Contact Research Centre

Neoplasm malignant

Not yet recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gemcitabine
Sponsor:Sutro Biopharma Inc.

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

Investigational

Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
Sponsor:Prinnovation GmbH

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Registered drugNo placebo

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Busulfan
Sponsor:GPOH gGmbH

Contact Research Centre

Acute myeloid leukaemia+1

Not yet recruiting

Registered drugNo placebo

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Cytarabine
Sponsor:GPOH gGmbH

Contact Research Centre

Dementia Alzheimer's type

Not yet recruiting

Investigational

Study on JNJ-64042056 for Preclinical Alzheimer's Disease in Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Jnj-64042056
Sponsor:Janssen - Cilag International

Contact Research Centre

Neuroblastoma

Not yet recruiting

Registered drugNo placebo

Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Busulfan
Sponsor:University Of Cologne

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Registered drug

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Germany

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Aachen

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on lymphoma treatments and various forms of breast cancer therapies, including studies of novel immunotherapy combinations for head and neck cancers.

Diffuse Large B-Cell Lymphoma
Triple-Negative Breast Cancer
Non-small Cell Lung Cancer

Advanced therapeutic approaches including targeted treatments and combination therapies are being evaluated for improved patient outcomes.

02 Cardiovascular Studies

Research targeting heart failure prevention and management of cardiovascular complications, with emphasis on innovative drug combinations and preventive treatments.

Heart Failure Prevention
Cardiovascular Disease Management
Obesity-related Cardiac Conditions

Studies focus on reducing cardiovascular events and improving long-term patient outcomes.

03 Chronic Conditions

Clinical investigations addressing various chronic conditions, including inflammatory diseases and dermatological disorders.

Hidradenitis Suppurativa
Chronic Venous Ulcers
Inflammatory Myopathies

Evaluating new therapeutic approaches for managing long-term conditions and improving quality of life.

Back to Germany All countries